Source: Virtual Congress 2020 – Clinical data and COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. van Zelst (Rotterdam, Netherlands), L. Goossens (Rotterdam, Netherlands), M. Rutten- Van Molken (Rotterdam, Netherlands), J. In 'T Veen (Rotterdam, Netherlands). Stratifying COPD patients by cluster analysis using clinical and behavioral variables. 1004

Member's Comments

No comment yet.

Related content which might interest you: Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Cluster analysis of clinical phenotypes of OSA and its implications for comorbidities Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA) Year: 2021 Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Cluster analysis and clinical asthma phenotypes Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 The superexacerbator phenotype in patients with COPD: a descriptive analysis Source: ERJ Open Res, 5 (2) 00235-2018; 10.1183/23120541.00235-2018 Year: 2019 Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Clinical COPD phenotypes identified by cluster analysis: validation with mortality Source: Eur Respir J 2012; 40: 495-496 Year: 2012 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Comparison of prognostic significance of the quality of life questionnaires in patients with COPD combined with hypertension Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 How to predict COPD in a clinical setting Source: Annual Congress 2005 - New strategies and drugs for smoking cessation Year: 2005 Patient baseline variables predict future asthma control status and risk of exacerbations Source: Annual Congress 2010 - Management of airway disease Year: 2010 Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019